Autres langues BioMarin Pharmaceutical Inc.

Actions

BMRN

US09061G1013

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
80,91 ^USD	-1,53%		-8,71%	-16,09%

26/04	BIOMARIN PHARMACEUTICAL INC. : Scotiabank maintient son opinion neutre	ZM
25/04	BIOMARIN PHARMACEUTICAL INC. : Wells Fargo Securities maintient sa recommandation à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioMarin Pharmaceutical Q1 Non-GAAP EPS, Revenue Increase -- Shares Down After Hours	24/04
BioMarin: Q1 Earnings Snapshot	24/04
(BMRN) BIOMARIN PHARMACEUTICAL Forecasts Fiscal Year 2024 EPS Range $2.75 - $2.95	24/04
Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Posts Q1 Revenue $648.8M	24/04
Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Posts Q1 EPS $0.71	24/04
BioMarin Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
BioMarin Reports Record Financial Results for the First Quarter 2024	24/04
BioMarin Pharmaceutical : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K	23/04
BioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Says	22/04
Biomarin Pharmaceutical Insider Sold Shares Worth $3,645,000, According to a Recent SEC Filing	15/04
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET	10/04
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing	01/04
New Data to be presented for BioMarin's VOXZOGO in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting	13/03
BioMarin Pharmaceutical Says Voxzogo Leads to Height Gains in Children With Achondroplasia	12/03
ETF der Woche: Auf die Wende der Biotechs setzen	10/03
L'ETF della settimana: scommettere sull'inversione di tendenza delle biotech	09/03
ETF van de week: inzetten op de ommekeer in de biotech	08/03
Biomarin Pharmaceutical Insider Sold Shares Worth $348,280, According to a Recent SEC Filing	07/03
BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer	07/03
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer	07/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BioMarin Pharmaceutical Inc.

Actions

BMRN

US09061G1013

Autres langues

Filtres